The Association of Aspirin Use With Age-Related Macular Degeneration

Methods: A prospective analysis was conducted of data from an Australian population-based cohort with 4 examinations during a 15-year period (1992-1994 to 20072009). Participants completed a detailed questionnaire at baseline assessing aspirin use, cardiovascular disease status, and AMD risk factors. Age-related macular degeneration was graded side-by-side from retinal photographs taken at each study visit to assess the incidence of neovascular (wet) AMD and geographic atrophy (dry AMD) according to the international AMD classification.

[1]  Gianni Tognoni,et al.  Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials , 2012, The Lancet.

[2]  N. Sattar,et al.  Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. , 2012, Archives of internal medicine.

[3]  P. Mitchell,et al.  Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis , 2010, BMC ophthalmology.

[4]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[5]  B. Klein,et al.  Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort. , 2008, American journal of epidemiology.

[6]  A. Nicolucci.  Aspirin for primary prevention of cardiovascular events in diabetes: still an open question. , 2008, JAMA.

[7]  U. Schlötzer-Schrehardt,et al.  Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. , 2007, Molecular immunology.

[8]  P. Mitchell,et al.  Regular aspirin use and retinal microvascular signs: the Blue Mountains Eye Study , 2006, Journal of hypertension.

[9]  A. Hofman,et al.  Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. , 2004, Ophthalmology.

[10]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[11]  Johanna M Seddon,et al.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. , 2003, Ophthalmology.

[12]  P. Mitchell,et al.  Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study , 2003, Ophthalmic epidemiology.

[13]  J. Mitchell,et al.  Cyclooxygenase-3 (COX-3): Filling in the gaps toward a COX continuum? , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Paul Mitchell,et al.  Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.

[15]  R. Klein,et al.  Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. , 2001, Archives of ophthalmology.

[16]  J. Manson,et al.  Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians. , 2001, Archives of ophthalmology.

[17]  A Hofman,et al.  Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.

[18]  J. J. Wang,et al.  Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. , 1995, Ophthalmology.

[19]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[20]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[21]  S. Fine,et al.  Massive hemorrhage complicating age-related macular degeneration. Clinicopathologic correlation and role of anticoagulants. , 1986 .

[22]  G. Hänsch,et al.  Effect of salicylates on the complement system: generation of mediators in vivo and in vitro. , 1981, Clinical immunology and immunopathology.

[23]  P. D. de Jong,et al.  Associations between aspirin use and aging macula disorder: the European Eye Study. , 2012, Ophthalmology.

[24]  P. D. de Jong.  Aspirin and age-related macular degeneration. , 2010, Ophthalmology.

[25]  Paul Mitchell,et al.  Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. , 2007, Ophthalmology.